Howard B Rosen's Net Worth
$21.5 Thousand
Who is Howard B Rosen?
Howard B Rosen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COTHERIX INC, KALA BIO, Inc., ACELRX PHARMACEUTICALS INC, and PHARSIGHT CORP.
SEC CIK
Howard B Rosen's CIK is 0001307068
Past Insider Trading and Trends
2023 was Howard B Rosen's most active year for acquiring shares with 7 total transactions. Howard B Rosen's most active month to acquire stocks was the month of May. 2008 was Howard B Rosen's most active year for disposing of shares, totalling 5 transactions. Howard B Rosen's most active month to dispose stocks was the month of April. 2016 saw Howard B Rosen paying a total of $33,271.56 for 810,206 shares, this is the most they've acquired in one year. In 2008 Howard B Rosen cashed out on 46,832 shares for a total of $107,200.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COTHERIX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KALA BIO, Inc. (KALA) Snapshot price: $6.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.21% | 1.4K |
—
|
—
| 13.89K |
Jun 11
| |||
Form 4
| +267.37% | 9.09K |
—
|
—
| 12.49K |
Jun 22
| |||
Form 4
| +278.93% | 2.5K |
—
|
—
| 3.4K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +80.57% | 20K |
—
|
—
| 44.82K |
Jun 17
| |||
Form 4
| +414.59% | 20K |
—
|
—
| 24.82K |
Jun 25
| |||
Form 4
|
∞
| 4.82K |
$0.60 | $2,872.08 | 4.82K |
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +154.32% | 5K |
$5.42 | $27,100.00 | 8.24K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACELRX PHARMACEUTICALS INC (ACRX) No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.33% | 581 |
—
|
—
| 5.29K |
Oct 10
| |||
Form 4
| +19.68% | 15.5K |
—
|
—
| 94.25K |
Jul 15
| |||
Form 4
| +14.55% | 10K |
—
|
—
| 78.75K |
Jun 17
| |||
Form 4
| +12.24% | 7.5K |
—
|
—
| 68.75K |
Jun 16
| |||
Form 4
| +6.52% | 3.75K |
—
|
—
| 61.25K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +25.65% | 10.21K |
$3.26 | $33,271.56 | 50K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
| +805.64% | 35.4K |
—
|
—
| 39.79K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
∞
| 4.39K |
—
|
—
| 4.39K |
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PHARSIGHT CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |